[ET Net News Agency, 27 August 2021] HANSOH PHARMA (03692) fell 4.96% to HK$21.1.
It hits an intra-day low of HK$20.95, hitting a 52-week low, and an intra-day high of
HK$21.7. The total shares traded was 804,000, with a value of HK$17.17m. The active
buy/sell ratio is 60:40, with net buying turnover of HK$3.21m. MORGAN STANLEY HK SEC
accounts for greatest net responsive buying turnover of HK$1.16m, with volume weighted
average price of HK$21.356. CREDIT SUISSE (HK) SEC accounts for greatest net responsive
selling turnover of HK$1.69m, with volume weighted average price of HK$21.38. The stock
has fallen a combined 6.84% over the past 3 consecutive trading days.
The Hang Seng Index now rose 11 points, or 0.05% to 25,427; the Hang Seng China
Enterprises Index now rose 33 points, or 0.37% to 8,970; the Hang Seng TECH Index now rose
38 points, or 0.61% to 6,375; with an overall turnover of HK$13.27b.
The SSE Composite Index now rose 8 points, or 0.24% to 3,510, with an overall turnover
of RMB94.18b.
The SZSE Component Index now rose 24 points, or 0.17% to 14,440, with an overall
turnover of RMB48.3b.
Basic Information
-------------------------------------------
Nominal 21.100 % Chg -4.96%
High 21.700 Low 20.950
Shares Tr 804,000 Turnover 17.17m
10-D SMA 23.720 %H.V 47.838
20-D SMA 25.648 VWAP 21.351
50-D SMA 29.171 RSI14 23.992
-------------------------------------------
Status: Hitting a 52-week low, active buy/sell ratio is 60:40, with net buying turnover
of HK$3.21m, falling a combined 6.84% over the past 3 consecutive trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
HANSOH PHARMA (03692) 21.10 -4.96
CMS (00867) 15.48 -0.90
CSPC PHARMA (01093) 9.84 -1.99
SINO BIOPHARM (01177) 6.25 -0.16
LIVZON PHARMA (01513) 29.50 -0.51
3SBIO (01530) 7.68 +3.23
SIMCERE PHARMA (02096) 7.95 +3.79
FOSUN PHARMA (02196) 52.00 +1.17
WUXI APPTEC (02359) 144.30 +0.84
PHARMARON (03759) 160.90 +0.63
-------------------------------------------------
(ed)